A Phase 1, Open-Label, Single-Dose, Non-Randomized Study to Evaluate Pharmacokinetics and Pharmacodynamics of Edoxaban in Pediatric Patients
Phase of Trial: Phase I
Latest Information Update: 15 Nov 2017
At a glance
- Drugs Edoxaban (Primary)
- Indications Atrial fibrillation; Deep vein thrombosis; Embolism; Pulmonary embolism; Stroke; Venous thromboembolism; Venous thrombosis
- Focus Pharmacokinetics
- Sponsors Daiichi Sankyo Inc
- 10 Jun 2017 Biomarkers information updated
- 18 Nov 2016 Planned number of patients changed from 48 to 60.
- 18 Nov 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.